meta-analysis

Ibrahim M, Tariq S, Afridi MK, Zafar A, Khamisani FA, Aminpoor H, Arfin SMW, Fonarow GC, Greene SJ, Musani MH, Waqas SA. Potent P2Y12 Inhibitor[...]

Farmakis IT, Binder H, Chopard R, Christodoulou KC, Evrenoglou T, Fengler K, Giri J, Hobohm L, Jaber WA, Klok FA, Kocka V, Kroupa J, Kucher[...]

Ibrahim M, Kashif A, Arfin SMW, Mubeen M, Zafar A, Balach R, Musani MH, Greene SJ, Fonarow GC, Sohail MU. Efficacy and Safety of Mavacamten[...]

Riemann S, Meulmeester FL, Mailhot-Larouche S, Ramakrishnan S, Wechsler ME, Corren J, Diver SE, Brightling CE, Castro M, Hanania NA, Jackson DJ, Martin N, Laugerud[...]

Kumburegama BWMB, Kristensen AT, Bjelakovic G, Nikolova D, Asante MA, Bjelakovic M, Koretz RL, Balakumar MM, Michelsen ME, Klingenberg SL, Gluud C. Direct-acting antivirals for[...]

Waqas M, Ahmed M, Ibrahim M, Nasir M, Afridi MK, Fonarow GC, Waqas SA. Efficacy and Safety of Direct Oral Anticoagulants for Extended Treatment of[...]

Khalid A, Balach R, Rasool A, Daniyal SM, Nizami MT, Gul I, Naqvi A, Fonarow GC, Waqas SA. Clinical outcomes and safety of SGLT2 inhibitors[...]

Ahmed M, Hashmi TM, Shafiq A, Ashraf H, Jain H, Khanji MY, Providência R, Chahal AA, Rana JS, Farhan M, Ahmed R, Fudim M, Fonarow[...]

Sheppard JP, Palatnic L, Lakshmanan S, Drago T, Bhogal J, Roy SK, Bhatt DL, Budoff MJ, Nelson JR. Effects of Eicosapentaenoic Acid vs Eicosapentaenoic/Docosahexaenoic Acids[...]

Ahmed M, Zulfiqar E, Ashraf H, Hashmi TM, Ahmed R, Rana JS, Greene SJ, Mentz RJ, Fudim M, Fonarow GC. Reduced-dose vs full-dose direct oral[...]